Captrust Financial Advisors Regenxbio Inc. Transaction History
Captrust Financial Advisors
- $43.1 Billion
- Q2 2025
A detailed history of Captrust Financial Advisors transactions in Regenxbio Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 10,414 shares of RGNX stock, worth $133,507. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,414Holding current value
$133,507% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding RGNX
# of Institutions
182Shares Held
45.2MCall Options Held
103KPut Options Held
100K-
Black Rock Inc. New York, NY8.61MShares$110 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.78MShares$61.2 Million4.77% of portfolio
-
Jpmorgan Chase & CO New York, NY4.36MShares$56 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.42MShares$43.9 Million0.0% of portfolio
-
State Street Corp Boston, MA1.84MShares$23.6 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $554M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...